You do not want to discard half a vial because the 28-day window closed before you could use it all
[1] For gut health applications, the oral route has the most direct mechanistic support
The state of New York, where he was also allowed to practice, ordered him to surrender his medical license there
Pharmacokinetic analysis showed a significant reduction in both the maximum serum concentration (Cmax) and area under the curve (AUC) for acetaldehyde in the GSH group, further confirming the efficacy of GSH in accelerating acetaldehyde clearance from the bloodstream
10.1053/j.gastro.2015.09.039 47 KoppelmannT.PollakY.MogilnerJ.BejarJ.CoranA
FOXO4-DRI Key Research Facts Full name: FOXO4 D-Retro-Inverso peptide (FOXO4-DRI) Classification: Cell-penetrating senolytic peptide FOXO4/p53 protein-protein interaction inhibitor Design: D-retro-inverso isoform of FOXO4s p53-binding domain reversed sequence with all D-amino acids Binding target: p53 transactivation domain 2 (TAD2) displaces FOXO4 from the FOXO4-p53 complex Mechanism: FOXO4-DRI binds p53 TAD2 p53 nuclear exclusion p53 mitochondrial translocation BAX activation caspase-3 cleavage senescent cell-selective apoptosis Selectivity basis: FOXO4 is upregulated in senescent cells but expressed at low levels in most non-senescent adult cells selectivity is mechanistically conferred D-amino acid advantage: Proteolytic stability resistant to intracellular peptidases that would rapidly degrade equivalent L-amino acid sequences Structural characterisation: NMR structural models of FOXO4-DRI/p53TAD2 complex resolved (Nature Communications, 2025) confirms disordered-to-ordered transition upon binding Research cell types studied: IMR90 fibroblasts, TM3 Leydig cells, endothelial cells, chondrocytes, keloid fibroblasts, HCT116 cancer cells In vitro working concentration: 25 M used in multiple published studies for senescent cell apoptosis induction What Does FOXO4-DRI Do in Research
